Probiotix Health plc (PBX) ORD GBP0.05

Sell:7.50pBuy:9.00p0.75p (9.09%)

Prices delayed by at least 15 minutes
Sell:7.50p
Buy:9.00p
Change:0.75p (9.09%)
Prices delayed by at least 15 minutes
Sell:7.50p
Buy:9.00p
Change:0.75p (9.09%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
9 June 2025
Michael LitichevskiGroup Director
Buy
Regular purchase transaction
67,5007.70p519,750.00p0
29 May 2025
Michael LitichevskiGroup Director
Buy
Regular purchase transaction
75,7807.25p549,405.00p0
29 May 2025
Mads BrandtGroup Director
Buy
Regular purchase transaction
188,9457.83p1,479,439.35p0
29 May 2025
Mark Kingsley CollingbourneCFO
Buy
Regular purchase transaction
108,9077.25p789,575.75p200,000
29 May 2025
Adam ReynoldsChairman of the Board
Buy
Regular purchase transaction
50,0007.88p394,000.00p192,857
29 May 2025
Steen Dannemann AndersenCEO
Buy
Regular purchase transaction
125,4507.83p982,273.50p125,450
1 November 2024
Mark Kingsley CollingbourneCFO
Buy
Regular purchase transaction
80,000£5.50£440,000.0091,093

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
29 May 2025
Mads BrandtGroup Director
Buy
Regular purchase transaction
188,9457.83p1,479,439.35p0
29 May 2025
Steen Dannemann AndersenCEO
Buy
Regular purchase transaction
125,4507.83p982,273.50p125,450
29 May 2025
Mark Kingsley CollingbourneCFO
Buy
Regular purchase transaction
108,9077.25p789,575.75p200,000
29 May 2025
Michael LitichevskiGroup Director
Buy
Regular purchase transaction
75,7807.25p549,405.00p0
9 June 2025
Michael LitichevskiGroup Director
Buy
Regular purchase transaction
67,5007.70p519,750.00p0

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.